 |
 |
 |
Search IPO GMP:
Q-Line Biotech IPO GMP
Q-Line Biotech IPO is an SME IPO, the company will raise up to 214 crore 48 lakh 47 thousand Six hundred rupees for 62,53,200 shares. The IPO comprises a fresh issue of 62,53,200 shares (aggregating up to 214 crore 48 lakh 47 thousand Six hundred rupees), and an offer for sale (OFS) of NIL.
| Q-Line Biotech IPO GMP (Grey Market Premium) | |
| Premium From IPO Cut-off Price | |
| IPO Price Band | ₹326 to ₹343 per share |
Q-Line Biotech IPO Latest GMP (Grey Market Premium) Today
Visit us daily to get the latest update on IPO GMP. You will get the latest update of SME IPO GMP.
Q-Line Biotech IPO Lates GMP (grey market premium) available here
- Price Band of Q-Line Biotech IPO is ₹326 to ₹343 per share.
- Current GMP (Grey Market Premium) for Q-Line Biotech IPO is:
- It is a premium for the IPO cut-off price .
- As per Q-Line Biotech IPO Taday’s GMP Data, the estimated listing price of Q-Line Biotech IPO shares can be:
- Estimated listing price calculated as Q-Line Biotech IPO cutoff price or allotment price: ₹343 per share + IPO current GMP: .
Q-Line Biotech SME IPO GMP |
||
| Date | GMP (₹) | Listing Price (₹-Estimated) |
| Today | 103 | |
| 27 May 2026 | 103 | |
| 26 May 2026 | 103 | |
| 25 May 2026 | 108 | |
| 24 May 2026 | 105 | |
| 23 May 2026 | 105 | |
| 22 May 2026 | 113 | |
| 21 May 2026 | 108 | |
| 20 May 2026 | 103 | |
| 19 May 2026 | 90.50 | |
| 18 May 2026 | 48 | |
| 17 May 2026 | 0 | |
Total shares offered by Q-Line Biotech IPO is 62,53,200 shares (aggregating up to 214 crore 48 lakh 47 thousand Six hundred rupees). Out of which 20,79,200 shares (33.25%) is reserved for retail, 8,91,600 shares (14.26%) is reserved for HNI (NII), 29,69,200 shares (47.48%) is reserved for QIB, and 3,13,200 shares (5.01%) is reserved for market maker Hem Finlease Pvt Ltd.
Q-Line Biotech IPO will open for subscription on 21 May 2026 and close on 25 May 2026. Basis of allotment will be decided on 26 May 2026, initiation of refund will begin on 27 May 2026 and finally IPO will be listed on 29 May 2026 at NSE SME. Hem Securities Ltd and Share India Capital Services Pvt Ltd is the book running lead manager and Purva Sharegistry (India) Pvt Ltd is the registrar of the Q-Line Biotech IPO.
Q-Line Biotech IPO Price Band and Market Lot
Q-Line Biotech has set a price band of ₹326 to ₹343 per share and lot size is of . Retail investors can bid for a minimum and maximum of 2 lots (800 shares), requiring an investment of ₹2,74,400, sHNI investors can bid for a minimum of 3 lots (1,200 shares), requiring an investment of ₹4,11,600 and bHNI investors can bid for a minimum of 8 Lots (3,200 shares), requiring an investment of ₹10,97,600 calculated at the cut-off price ₹343 per share (the upper end of the price band).
| Q-Line Biotech IPO Price | |
| Face Value | ₹10 per share |
| Price Band | ₹326 to ₹343 per share |
| Lot Size | 400 shares |
| IPO Issue Type | Book Built Issue |
About Q-Line Biotech
Incorporated in 2010 (operations began in 2013 as POCT Services Private Limited, later renamed Q-Line Biotech), headquartered in Lucknow, Uttar Pradesh, Q-Line Biotech Limited is a leading Indian In-Vitro Diagnostic (IVD) company specializing in the indigenous manufacturing of diagnostic reagents, consumables, rapid testing kits, and pathology equipment.Q-Line Biotech IPO GMP FAQs
The latest Grey Market Premium (GMP) of Q-Line Biotech IPO is .
It is a premium to the IPO cut-off price Q-Line Biotech. GMP gives a rough estimate of the premium at which the stock might list. It’s not guaranteed but often aligns with market sentiment.
As per latest GMP data, the expected return for Q-Line Biotech IPO can be .
Expected listing listing price for Q-Line Biotech share can be .
According to latest GMP data pattern expected listing price and profit per share for Q-Line Biotech IPO can be . Expected listing price is calculated by adding the GMP to the IPO issue price. Estimated listing price = IPO issue price + current GMP. This value changes as the GMP fluctuates.
GMP is an unofficial indicator and can be manipulated. It should never be the sole reason to apply. Always consider fundamentals and risk tolerance. Subscription demand, financial performance, market sentiment, peer valuation, and overall liquidity can impact the GMP trend.
Grey Market Premium (GMP) refers to the unofficial over-the-counter market where IPO shares or applications are traded before listing on stock exchanges. GMP data is based on market speculation, demand, subscriptions, and market sentiment, and may change rapidly without notice. Since the grey market is unregulated, GMP figures may be volatile, inaccurate, or subject to manipulation.
GMP should not be considered the sole basis for making investment decisions. The information provided by MarketBandhu is for informational purposes only (gathered from various sources) and does not constitute financial, investment, or trading advice. MarketBandhu does not recommend buying, selling, or subscribing to any IPO based solely on GMP data.